Diagnosis and Management of Eosinophilic Esophagitis

Overview

Journal CMAJ

Date 2024 Feb 5

PMID 38316452

Authors

Milli Gupta

Michelle Grinman

Affiliations

Soon will be listed here.

Citing Articles

Eosinophilic esophagitis and inhalant antigens: Pointing out the roles of allergic rhinitis, immunotherapy and biologic treatment.

Ridolo E, Nicoletta F, Lombardi C, Passalacqua G, Senna G, Canonica G World Allergy Organ J. 2024; 17(10):100968.

PMID: 39386073 PMC: 11462258. DOI: 10.1016/j.waojou.2024.100968.

Monitoring for eosinophilic esophagitis in food oral immunotherapy.

Jeimy S, Chan E, Cook V CMAJ. 2024; 196(28):E980.

PMID: 39187285 PMC: 11349345. DOI: 10.1503/cmaj.150958-l.

Correction to "Diagnosis and management of eosinophilic esophagitis".

CMAJ. 2024; 196(8):E268.

PMID: 38438156 PMC: 10911862. DOI: 10.1503/cmaj.240239.

References

Patel D, Yadlapati R, Vaezi M . Esophageal Motility Disorders: Current Approach to Diagnostics and Therapeutics. Gastroenterology. 2022; 162(6):1617-1634. PMC: 9405585. DOI: 10.1053/j.gastro.2021.12.289. View

Lucendo A, Molina-Infante J, Arias A, von Arnim U, Bredenoord A, Bussmann C . Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterol J. 2017; 5(3):335-358. PMC: 5415218. DOI: 10.1177/2050640616689525. View

Spechler S, Genta R, Souza R . Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol. 2007; 102(6):1301-6. DOI: 10.1111/j.1572-0241.2007.01179.x. View

Arias A, Lucendo A . Epidemiology and risk factors for eosinophilic esophagitis: lessons for clinicians. Expert Rev Gastroenterol Hepatol. 2020; 14(11):1069-1082. DOI: 10.1080/17474124.2020.1806054. View

Ma C, Schoepfer A, Dellon E, Bredenoord A, Chehade M, Collins M . Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS). J Allergy Clin Immunol. 2021; 149(2):659-670. PMC: 8733049. DOI: 10.1016/j.jaci.2021.07.001. View

Hill D, Grundmeier R, Ramos M, Spergel J . Eosinophilic Esophagitis Is a Late Manifestation of the Allergic March. J Allergy Clin Immunol Pract. 2018; 6(5):1528-1533. PMC: 6131029. DOI: 10.1016/j.jaip.2018.05.010. View

Dellon E, Woosley J, Arrington A, McGee S, Covington J, Moist S . Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial. Gastroenterology. 2019; 157(1):65-73.e5. PMC: 6581596. DOI: 10.1053/j.gastro.2019.03.014. View

Hirano I, Chan E, Rank M, Sharaf R, Stollman N, Stukus D . AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis. Gastroenterology. 2020; 158(6):1776-1786. PMC: 9473154. DOI: 10.1053/j.gastro.2020.02.038. View

Wang F, Gupta S, Fitzgerald J . Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children?. J Clin Gastroenterol. 2007; 41(5):451-3. DOI: 10.1097/01.mcg.0000248019.16139.67. View

10.

Jensen E, Shah N, Hoffman K, Sonnenberg A, Genta R, Dellon E . Seasonal variation in detection of oesophageal eosinophilia and eosinophilic oesophagitis. Aliment Pharmacol Ther. 2015; 42(4):461-9. PMC: 4506219. DOI: 10.1111/apt.13273. View

11.

Lucendo A, Miehlke S, Schlag C, Vieth M, von Arnim U, Molina-Infante J . Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial. Gastroenterology. 2019; 157(1):74-86.e15. DOI: 10.1053/j.gastro.2019.03.025. View

12.

Dellon E, Erichsen R, Baron J, Shaheen N, Vyberg M, Sorensen H . The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark. Aliment Pharmacol Ther. 2015; 41(7):662-70. PMC: 4504237. DOI: 10.1111/apt.13129. View

13.

Cifra N, Lomas J . Differentiating Eosinophilic Esophagitis and Eating/Feeding Disorders. Pediatrics. 2022; 149(4). DOI: 10.1542/peds.2021-052889. View

14.

Leigh L, Spergel J . An in-depth characterization of a large cohort of adult patients with eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2018; 122(1):65-72.e1. DOI: 10.1016/j.anai.2018.09.452. View

15.

Chang J, Kliewer K, Haller E, Lynett A, Doerfler B, Katzka D . Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2023; 21(7):1690-1698. PMC: 10293042. DOI: 10.1016/j.cgh.2023.03.006. View

16.

Hirano I, Furuta G . Approaches and Challenges to Management of Pediatric and Adult Patients With Eosinophilic Esophagitis. Gastroenterology. 2019; 158(4):840-851. PMC: 8063595. DOI: 10.1053/j.gastro.2019.09.052. View

17.

Robson J, Laborda T, Fitzgerald S, Andersen J, Peterson K, OGorman M . Avoidant/Restrictive Food Intake Disorder in Diet-treated Children With Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr. 2019; 69(1):57-60. DOI: 10.1097/MPG.0000000000002323. View

18.

von Arnim U, Biedermann L, Aceves S, Bonis P, Collins M, Dellon E . Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice - International Expert Recommendations. Clin Gastroenterol Hepatol. 2022; 21(10):2526-2533. DOI: 10.1016/j.cgh.2022.12.018. View

19.

Schoepfer A, Safroneeva E, Bussmann C, Kuchen T, Portmann S, Simon H . Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013; 145(6):1230-6.e1-2. DOI: 10.1053/j.gastro.2013.08.015. View

20.

Alexander J . Topical steroid therapy for eosinophilic esophagitis. Gastroenterol Hepatol (N Y). 2014; 10(5):327-9. PMC: 4076881. View